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Abstract: We have shown previously that neurons in the mouse spinal cord express Gb3. 
We show in this article that distribution of anti-Gb3-Ab reactivity occurs in many different 
types of neurons of different areas of the central nervous system (CNS). The 
immunoreactive neurons are in olfactory bulbs, cerebral cortex, hippocampus, striatum, 
amygdala, thalamus, hypothalamus, cerebellum, and medulla oblongata. In several 
different circumventricular organs where vessels do not have the blood-brain-barrier 
(BBB) structure, anti-Gb3-Ab is not positive for vessel structures, while neurons at these 
regions are positive. Also, within the ventricular area, ependymal cells in the third ventricle 
express Gb3, as revealed by anti-Gb3-Ab staining and intensity analysis. 
Keywords:  globotriaosylceramide (Gb3); neuron; circumventricular organs (CVO); 
ependymal cells 
 
1. Introduction 
In Shiga-toxin producing Escherichia coli (STEC) infections, a broad spectrum of central nervous 
system (CNS) symptoms occurs (abbreviations used in this article are listed in Table 1). Those 
symptoms include cortical blindness, poor fine-motor coordination, seizures and coma [1–13]. 
Globotriaosylceramide (Gb3) is a known receptor of Shiga toxin (Stx), which is central to the 
intoxication and disease process [14]. It has been shown that a Gb3 knockout mouse is resistant to  
Stx [15]. To understand target components within the CNS, determining which cell types express Gb3 
is essential. Previously, we reported that in the mouse CNS, Shiga toxin-2 acts on spinal cord neurons 
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which express Gb3, and leads to hindlimb paralysis [16]. Other mouse CNS cell types expressing Gb3 
have not been described in detail. 
Table 1. Abbreviations used in this manuscript. 
Abbreviation Abbreviated  Term 
AP  Area postrema 
(e)
ARH  Arcuate nucleus of hypothalamus 
(c) 
BBB  Blood-brain-barrier 
BLA  Basolateral nucleus of the amygdala 
(c) 
CNS  Central nervous system 
CP Caudate-putamen 
(a) 
CSF  Cerebro-spinal fluid 
CVO Circumventricular  organs 
DMX  Dorsal motor nucleus of the vagus 
(e) 
ec External  capsule 
(c)
MD  Mediodorsal nucleus of the thalamus 
(d) 
ME Median  eminence 
(c) 
MH  Medial habenula 
(d)
NTS  Nucleus of the solitary tract 
(e) 
OVLT  Organum vasculosum of the lamina terminalis 
(b) 
PVT  Paraventricular nucleus of the thalamus 
(d) 
SCO  Subcommissural organ 
SFO Subfornical  organ 
(d)
V3  Third ventricle 
V4 Fourth  ventricle 
VL  Lateral ventricle 
XII Hypoglossal  nucleus 
(e)
(a) See Figure 2d for the positional information; (b)See Figure 4b for the positional information; 
(c) See Figure 4d for the positional information, (d) See Figure 4f for the positional information. 
The trafficking route of Stx into the CNS is as important as determining its target. In human STEC 
patients’ brain magnetic resonance imaging (MRI), regions as the basal ganglia and also thalamus, 
cerebellum and brain stem, are found positive for increased permeability of fluid [17–20]. In a rabbit 
model, MRI showed enhanced permeability in the area surrounding V3 after Stx injections [21]. 
However, precise Stx trafficking routes and the mechanisms involved are still in question. 
Circumventricluar organs (CVO) are known to be devoid of the blood-brain-barrier (BBB), thus 
exchange of substances between the plasma and the CNS parenchyma is relatively easy [22]. The CVO 
is situated around the V3 (OVLT, SFO, ME, posterior pituitary, pineal gland and SCO) as well as the 
V4 (AP). Also, the choroid plexus located at both V3 and V4, is sometimes considered as the CVO. If 
the vessels at the CVO are expressing Gb3, it may increase the chance of being the primary target in 
the CNS. In this article, Gb3 expression in the CVO is addressed. Ependymal cells form a lining of the 
ventricle, which separates cerebro-spinal fluid (CSF) and parenchyma. As the choroid plexus makes 
CSF from serum and secretes it into the ventricles, there is a possibility of Stx2 in serum being 
transferred to the ventricle. If ependymal cells express Gb3, this also could be an entry point of Stx into 
the CNS parenchyma.  Toxins 2010, 2                     
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2. Materials and Methods  
2.1. Animals  
Specific pathogen-free C57BL/6 mice, male, 20–22 g body weight (b.w.) were purchased from 
Charles River (Wilmington, MA, USA). Mice were given food and water ad libitum. All procedures 
were approved by the University of Maryland School of Medicine Animal Care and Use Committee.  
A total of 5 mice were used in this study. 
2.2. Tissue Harvesting 
Mice were euthanized by CO2 inhalation. Two mice were perfused with 20 mL saline, followed by 
20 mL 4% paraformaldehyde/phosphate buffered saline (4% PFA/PBS). Brains were marked for the 
Bregma position (the crossing point of the coronal suture and the sagittal suture on the skull) with a 
knife incision. Brains and spinal cords were harvested, and further fixed in 4% PFA/PBS overnight at 
room temperature. Brains and spinal cords from 3 mice were fixed in the same manner without 
perfusion. Brains were trimmed to 2 mm thickness from the Bregma to both rostral and caudal ends. 
Spinal cords were trimmed into cervical, thoracic and lumbar segments. After incubating in 30% 
sucrose/PBS at 4 °C overnight, trimmed segments were sectioned to 50 m thickness using a sliding 
microtome (SM2000R, Leica Microsystems, Bannockburn, IL, USA). The positions of brain sections 
from the Bregma was determined with reference to a C57BL/6 brain atlas [23]. Sections were collected 
and held in PBS at 4 °C until use. 
2.3. Immunofluorescence Staining of Free-Floating Sections  
Staining was done according to Obata et al. [16] and Kolling et al. [24]. Antibodies used in this study 
were anti-Gb3 monoclonal antibody (MAb) (Beckman Coulter, Brea, CA, USA), anti-NeuN MAb (a 
neuronal marker, Millipore, Billerica, MA, USA) and Cy3 conjugated anti-GFAP MAb (an astrocytic 
marker, Sigma-Aldrich, St. Louis, MO, USA), at dilutions of 1:100, 1:1000, and 1:1000, respectively. 
For isotype matched controls, rat IgM (Millipore) and mouse IgG1 (Millipore) were used at dilutions of 
1:100 and 1:100, respectively. 4’,6-Diamidino-2-phenylindole (DAPI) was used to visualize nuclei. A 
Zeiss LSM510 microscope (Carl Zeiss Inc., Thornwood, NY, USA) was utilized in this study. 
2.4. Intensity Analysis of Anti-Gb3 Immunofluorescence  
For line profile intensity analysis, a LSM510 software line profile function was used. Within one 
image, a fixed length line was used to collect intensity data. Three intensity samples of neuronal and 
ependymal cytoplasm were collected per image. Appearance of high intensity of 2000 or higher was 
expressed as percentage of total data collected from the line profile. The VL, V3 and central canal 
regions were analyzed. Six images from each area were taken randomly from 3 mice, which were 
selected from a total of 5 mice (either perfuse-fixed or none perfuse-fixed). Averages of high intensity 
(%) between neurons and ependymal cells were compared. For area intensity analysis, Image-Pro Plus 
software (MediaCybernetics, Inc., Silver Spring, MD, USA) was used. The image acquired by 
LSM510 was saved as Tagged Image File Format (TIFF) in RGB, and only green channel   Toxins 2010, 2                     
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(Gb3-AlexaFluor488) was retained in the image using Adobe Photoshop 7.0 (Adobe Systems Inc., San 
Jose, CA, USA). The TIFF image was converted to Gray scale, and a fixed area (m
2) of region of 
interest (ROI) was made using Image-Pro Plus. The intensity range higher than background pixels was 
chosen, and 3 ROI areas within neuronal or ependymal cytoplasm per image were taken as intensity 
samples. The equivalent regions and number of samples comparable to those used in the Line profile 
intensity analysis were analyzed by the area intensity analysis method. Averages of ROI areas between 
neurons and ependymal cells were compared.  
2.5. Statistics 
Data from line profile or area intensity analysis were analyzed by student t-test (paired two-tail 
test), and p-values less than 0.01 were determined as significant. 
3. Results and Discussion 
Anti-Gb3-Ab reactive neurons were seen throughout the mouse CNS. In the olfactory bulb, where 
Mitral cells accept input from nasal epithelium cells to sense smell, and interneurons such as 
periglomerular cells and granule cells reside, all neurons were Gb3 positive (Figure 1). In the cerebrum, 
neurons in the cortex, including motor cortex were also Gb3 positive (Figure 2a). Astrocytes in the 
corpus callosum which is close to the cerebral cortex were Gb3 negative (Figure 2b,c). Hippocampus 
neurons, CA1, 2, 3 and dentate gyrus, were Gb3 positive (Figure 2e). Also, the neurons in the striatum 
(Figure 2b), amygdala (Figure 4i), thalamus (Figure 4e) and hypothalamus were Gb3 positive. The 
hypothalamic nuclei (ARH) neurons are shown to be Gb3 positive in Figure 4c. In the cerebellum, 
Perkinje cells as well as granule cells were also Gb3 positive (Figure 3). Neurons throughout the 
mouse CNS appeared to express Gb3, hence, depending on the CNS entry site of Stx, all these neurons 
could become targets of the toxin.  
Figure 1. Anti-Gb3-Ab staining of Olfactory bulb. (a) Olfactory bulb sections stained with 
anti-Gb3-Ab (Green), and anti-GFAP-Ab (Red) and DAPI (Blue). Glomerular layer (glom), 
external plexiform (ex pl), Mitral cell layer (M) and granular layer (gr) are visible as 
neurons are stained anti-Gb3. Bar indicates 100 m. (b) High magnification of glomerular 
layer. Arrowheads point to anti-Gb3-Ab reactive periglomerular neurons. Bar indicates   
10 m. (c) High magnification of Mitral cell layer. Arrows show anti-Gb3-Ab positive 
Mitral cells. Bar indicates 10 m. 
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Figure 2. Anti-Gb3-Ab staining of cerebrum. (a) Motor cortex region showing anti-Gb3 
stain (Green) in 2-6 layers of neurons, which are also positive for neuron specific   
anti-NeuN-Ab (Red). Position of the image corresponding to the Bregma 0.90 mm is 
shown in (d) as a square. (b) Corpus callosum region of the same section is shown. 
Astrocyte rich corpus callosum (*) is anti-Gb3 and anti-NeuN negative. Lower left area to 
corpus callosum is striatum (CP). Note that neurons of this area are also positive for   
anti-Gb3 Ab. Bar indicates 100 m. (c) Corpus callosum region is stained with   
anti-Gb3-Ab (Green) and anti-GFAP-Ab (an astrocytic marker, Red). Contrast of GFAP 
(Red) positive layer versus cortex neurons (Green) is clear. Bar indicates 100 m.   
(d) Coronal architectural positions at Bregma 0.90 mm is shown with indication of images 
(a), (b) and (c) in squares. (e) Hippocampus region is shown with anti-Gb3-Ab (Green) 
stain. Neuronal layers of CA1, 2, 3 and dentate gyras are anti-Gb3 positive. Area in (e) is 
shown as a rectangle in (f). Bar indicates 100 m. (f) Coronal section architecture at Bregma  
−2.40 mm is shown. (d) and (f) are modified from [23]. 
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Figure 3. Anti-Gb3-Ab staining of cerebellum. (a) Cerebellum sections were stained with 
anti-Gb3 Ab (Green), anti-GFAP-Ab (Red) and DAPI (Blue). Perkinje layer is shown 
reactive to anti-Gb3-Ab. Bar indicates 100 m. (b) Higher magnification of (a). Arrows 
indicate anti-Gb3-Ab positive Perkinje cells, while arrowheads indicate anti-Gb3-Ab 
positive neurons in the granule layer. Bar indicates 10 m.  
 
CVO areas in the mouse CNS were also tested for anti-Gb3-Ab reactivity. Within the tested CVO 
areas, none appeared to have a Gb3 expressing vessel structure. In contrast, neurons of these areas 
were positive for Gb3. In the OVLT, neurons which have characteristic large nuclei, were shown to be 
Gb3 positive (Figure 4a). In Figure 4c, the lining of V3 consisting of ependymal cells appears positive 
for Gb3. In Figure 4e, neurons in the SFO, as well as MH are Gb3 positive, while the choroid plexus is 
Gb3 negative. In Figure 4g, neurons in the medulla oblongata are Gb3 positive including the AP area. 
Within this image, a central canal positioned in the center, appears very dim.  
Ependymal cells were tested as a Gb3 expressing cell type and intensity analysis was performed 
comparing high intensity pixels in neuron and ependyma in the ventricle area as V3, VL and central 
canal. A square shaped region of interest (ROI) was used to detect the pixel area which is higher than 
background intensity. The average area (m
2) of neurons vs. ependymal cells in V3, VL and central 
canal was; 1.857 ± 0.039 vs. 1.773 ± 0.197 (p = 0.275), 1.567 ± 0.085 vs. 0.226 ± 0.262 (p = 0.0097), 
1.7739 ± 0.085 vs. 0.137 ± 0.275 (p = 0.0014), respectively. P values less than 0.01 were considered to 
be statistically significant, and shown as (*) in Figure 5a. The line profile intensity analysis revealed a 
similar result that averages of high intensity percent of neurons vs. ependyma in V3, VL and central 
canal were; 79.23 ± 23.29 vs. 71.41 ± 32.03 (p = 0.289), 66.31 ± 26.46 vs. 1.156 ± 2.997   
(p = 4.029E-10), 77.73 ± 30.39 vs. 4.346 ± 4.954 (p = 1.042E-08). The results are graphed in Figure 5b. 
In both analyses, the intensity level of Gb3 positive neurons and ependymal cells in the V3 region was 
similar, thus ependymal cells in this area were Gb3 positive. In contrast, VL and central canal 
ependymal cells were Gb3 negative.  
As the CVO is naturally leaky, serum Stx2 might travel through this route where vessels do not 
express Gb3. As ependymal cells at V3 express Gb3, this could serve as an entry point of Stx, if Stx 
enters into CSF in the mouse CNS. Trafficking of Stx in the CNS needs to be further investigated. Toxins 2010, 2                     
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Figure 4. Anti-Gb3-Ab staining of CVO areas (a) Anti-Gb3-Ab stain (Green) of OVLT 
region, which is depicted in (b) as Red. Arrowheads indicate the OVLT area;   
(b) Architectural structure of mouse Bregma 0.50 mm; (c) Anti-Gb3-Ab stain (Green) of a 
region containing ME, which is depicted in (d) as Red. Arrowheads indicate the ME area. 
Neurons in ARH, which are adjacent to ME are anti-Gb3-Ab reactive. The V3 is shown as 
a triangular area. A part of ependymal layer (square region) is shown in inset with higher 
magnification. (*) indicates a broken tissue space; (d) Architectural structure of mouse 
Bregma −1.30 mm; (e) Anti-Gb3-Ab stain (Green) of a region containing SFO, which is 
depicted in (f) as Red. Arrowheads indicate the SFO area, while arrows show anti-Gb3-Ab 
negative choroid plexus. Neurons of MH are also anti-Gb3-Ab reactive. Lower area of this 
field includes thalamic nuclei as PVT and MD, in which neurons are positive for   
anti-Gb3-Ab. (f) Architectural structure of mouse Bregma -0.90 mm; (g) Anti-Gb3-Ab stain 
(Green) of a region containing AP, which is depicted in (h) as Red. Arrowheads indicate 
AP area. Neurons of several different nuclei in the medulla oblongata such as NTS, DMX 
and XII are also anti-Gb3-Ab positive; (h) Architectural structure of mouse Bregma   
−8.10 mm; (i) Neurons in the amygdala are also anti-Gb3-Ab positive. BLA is indicated in 
the picture. Dotted line outlines external capsule (ec). See architectural structure in (d). All 
Bars indicate 100 m, except an inset in (c) which indicates 10 m. Blue color in (a) and (c) 
indicates nuclei staining using DAPI. (b), (d), (f) and (h) are modified from [23]. See 
abbreviations in Table 1. 
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Figure 4. Cont. 
 
Figure 5. Intesnsity of anti-Gb3-Ab staining in neurons vs. ependyma. (a) High intensity 
area comparison of neurons and ependymal cells from V3, VL or central canal. Values 
from each region (neuron vs. ependyma) are compared, and the statistically significant 
difference is shown as (*). (b) High intensity percentage from Line profile analysis 
comparing neurons and ependymal cells from V3, VL or central canal. Values from each 
region (neuron vs. ependyma) are compared, and statistically significant differences are 
shown as (*). * indicates p < 0.01 in 2-tailed, paired t-test. 
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4. Conclusions  
Mouse CNS neurons from various areas exhibited anti-Gb3-Ab reactivity. Ependymal cells at V3 
were also found to be positive for anti-Gb3-Ab reactivity. However, vessels at the CVO or other areas 
of the mouse CNS did not exhibit anti-Gb3 reactivity. 
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